Steve Hoffman
Directeur Général chez Tyme, Inc.
Postes actifs de Steve Hoffman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Directeur/Membre du Conseil | 01/07/2013 | - |
| Directeur Général | 01/07/2013 | - |
Historique de carrière de Steve Hoffman
Anciens postes connus de Steve Hoffman
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Directeur Général | 01/01/2014 | 24/11/2020 |
| Président | 01/01/2014 | 21/03/2022 | |
| Directeur Technique/Scientifique/R&D | 05/03/2015 | 21/03/2022 | |
| Fondateur | 22/11/2011 | 21/03/2022 | |
| Luminant Biosciences LLC | Directeur Général | 01/03/2015 | 01/10/2020 |
| Directeur Technique/Scientifique/R&D | 01/09/2011 | 01/10/2020 | |
| Fondateur | 01/09/2011 | 01/10/2020 | |
Mikronite Technologies Group, Inc.
 Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ. | Directeur Technique/Scientifique/R&D | 01/01/1993 | 01/01/2007 |
| Fondateur | 01/01/1993 | 01/01/2007 |
Statistiques
Internationale
| Etats-Unis | 5 |
Opérationnelle
| Chief Executive Officer | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
Sectorielle
| Health Technology | 3 |
| Producer Manufacturing | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Health Technology |
Mikronite Technologies Group, Inc.
Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ. | Producer Manufacturing |
| Luminant Biosciences LLC |
- Bourse
- Insiders
- Steve Hoffman
- Expérience